The role of HDAC8 of the development of peritoneal fibrosis in peritoneal dialysis patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052103

Enrollment

Unknown

Registered

2021-10-17

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal fibrosis

Interventions

Gold Standard:Pathology

Index test:HDAC8&#32

in&#32

dialysis&#32

effluent

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: The duration of peritoneal dialysis is 3 to 24 months and the situation is stable for at least 3 months.

Exclusion criteria

Exclusion criteria: Heart failure,myocardial infarction,active liver disease,trauma and surgery in the last 1 month.

Design outcomes

Primary

Measure	Time frame
HDAC8;	—

Countries

China

Contacts

Public ContactLiu Na

Shanghai East Hospital Affiliated to Tongji University School of Medicine

naliubrown@163.com+86 18217768587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026